ESK-001
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for ESK-001, covering 2024-07-23 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]